Max Healthcare Institute Limited
BSE: MAXINDIA
Prev Close
210.9
Open Price
210
Volume
5,729
Today Low / High
210 / 218
52 WK Low / High
52.3 / 218
Range
203 - 224
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 213.65, reflecting a change of 2.75 (1.3039%). The expected target range on the BSE is 203 - 224. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.
Max Healthcare Institute Limited Graph
Max Healthcare Institute Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Max Healthcare Institute Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 213.65, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 213.65 | 215.79 | 194.21 - 237.37 |
| 217.92 | 174.34 - 261.51 | ||
| 220.06 | 154.04 - 286.08 | ||
| Bearish Scenario | 213.65 | 211.51 | 190.36 - 232.66 |
| 209.38 | 167.50 - 251.25 | ||
| 207.24 | 145.07 - 269.41 |
Overview of Max Healthcare Institute Limited
ISIN
INE027H01010
Industry
Medical - Care Facilities
Vol.Avg
0
Market Cap
9,223,441,420
Last Dividend
0
Official Website
IPO Date
DCF Diff
N/A
DCF
0
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 7,028.46 Cr | 2,651.06 Cr | 4,377.40 Cr | 0.6228 | 0.76 Cr | 1,474.70 Cr | 2,902.70 Cr | 1,075.88 Cr | 11.07 | 1,800.53 Cr | 0.1531 |
| 2024-03-31 | 5,406.02 Cr | 2,052.92 Cr | 3,353.10 Cr | 0.6203 | 0.51 Cr | 1,116.89 Cr | 2,235.70 Cr | 1,057.64 Cr | 10.89 | 1,670.19 Cr | 0.1956 |
| 2023-03-31 | 4,562.60 Cr | 922.01 Cr | 3,640.59 Cr | 0.7979 | 0.36 Cr | 1,126.92 Cr | 1,024.02 Cr | 1,103.51 Cr | 11.38 | 1,379.77 Cr | 0.2419 |
| 2022-03-31 | 3,883.19 Cr | 922.90 Cr | 2,960.29 Cr | 0.7623 | -159.84 Cr | 908.19 Cr | 757.96 Cr | 605.05 Cr | 6.25 | 1,060.89 Cr | 0.1558 |
| 2021-03-31 | 2,482.41 Cr | 594.41 Cr | 1,888.00 Cr | 0.7606 | 0.00 Cr | 583.25 Cr | 243.05 Cr | -137.55 Cr | -1.59 | 284.90 Cr | -0.0554 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 681.89 Cr | 15,214.48 Cr | 5,833.61 Cr | 9,380.8700 Cr | 3,010.29 Cr | 2,328.40 Cr | 106.21 Cr | 6,362.38 Cr | 0.00 Cr | 233.62 Cr | 2.89 Cr | 1,813.7700 Cr |
| 2024-03-31 | 979.84 Cr | 11,999.94 Cr | 3,591.80 Cr | 8,408.1400 Cr | 1,507.89 Cr | 528.05 Cr | 79.84 Cr | 3,691.08 Cr | 49.15 Cr | 16.89 Cr | 2.12 Cr | 1,248.7100 Cr |
| 2023-03-31 | 42.75 Cr | 10,101.85 Cr | 2,692.26 Cr | 7,409.5900 Cr | 688.96 Cr | 646.21 Cr | 76.23 Cr | 2,225.63 Cr | 332.93 Cr | 11.73 Cr | 0.51 Cr | 1,045.5700 Cr |
| 2022-03-31 | 309.14 Cr | 9,189.13 Cr | 2,906.66 Cr | 6,282.4700 Cr | 1,132.67 Cr | 823.53 Cr | 61.36 Cr | 2,058.32 Cr | 118.84 Cr | 10.82 Cr | 2.02 Cr | 757.2700 Cr |
| 2021-03-31 | 626.59 Cr | 8,544.44 Cr | 2,905.76 Cr | 5,638.6800 Cr | 1,325.26 Cr | 698.67 Cr | 53.80 Cr | 1,774.91 Cr | 188.10 Cr | 11.41 Cr | 1.04 Cr | 776.9300 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1,459.3100 Cr | -1,631.7400 Cr | -163.8000 Cr | 493.7800 Cr | -318.6000 Cr | 661.2400 Cr | -965.5300 Cr | 1,075.8800 Cr | 295.7800 Cr | -145.5800 Cr | -19.2000 Cr |
| 2024-03-31 | 1,121.8000 Cr | -1,285.4500 Cr | -263.7400 Cr | 343.0200 Cr | -394.4900 Cr | 979.8400 Cr | -778.7800 Cr | 1,057.6400 Cr | 78.1300 Cr | -97.0100 Cr | 5.9000 Cr |
| 2023-03-31 | 1,209.1800 Cr | -1,187.0100 Cr | -288.5600 Cr | 873.5700 Cr | -266.3900 Cr | 42.7500 Cr | -335.6100 Cr | 1,063.7200 Cr | -161.7600 Cr | 0.0000 Cr | -14.8700 Cr |
| 2022-03-31 | 748.4900 Cr | -771.7700 Cr | -294.1700 Cr | 187.1800 Cr | -317.4500 Cr | 309.1400 Cr | -561.3100 Cr | 738.9000 Cr | -227.1600 Cr | 0.0000 Cr | -7.5600 Cr |
| 2021-03-31 | 117.8600 Cr | -73.0000 Cr | 191.3300 Cr | -0.5600 Cr | 515.5800 Cr | 626.5900 Cr | -118.4200 Cr | -68.6500 Cr | -791.1200 Cr | 0.0000 Cr | 17.2500 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 2,027.57 Cr | 445.24 Cr | 1,582.33 Cr | 0.7804 | 418.77 Cr | 307.97 Cr | 3.17 | 559.42 Cr | 0.1519 |
| 2025-03-31 | 1,909.74 Cr | 725.02 Cr | 1,184.72 Cr | 0.6204 | 778.38 Cr | 319.00 Cr | 3.28 | 488.58 Cr | 0.1670 |
| 2024-12-31 | 1,868.31 Cr | 391.82 Cr | 1,476.49 Cr | 0.7903 | 401.59 Cr | 238.80 Cr | 2.46 | 458.80 Cr | 0.1278 |
| 2024-09-30 | 1,707.46 Cr | 1,071.71 Cr | 635.75 Cr | 0.3723 | 366.39 Cr | 281.81 Cr | 2.90 | 491.38 Cr | 0.1650 |
| 2024-06-30 | 1,542.95 Cr | 1,001.18 Cr | 541.77 Cr | 0.3511 | 310.51 Cr | 236.27 Cr | 2.43 | 422.09 Cr | 0.1531 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 681.89 Cr | 0.00 Cr | 681.89 Cr | 687.31 Cr | 106.21 Cr | 1,592.57 Cr | 6,362.38 Cr | 15,214.48 Cr | 5,833.61 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 1,286.31 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -8,799.06 Cr |
| 2024-09-30 | 963.96 Cr | 322.35 Cr | 1,286.31 Cr | 528.69 Cr | 93.42 Cr | 1,980.76 Cr | 4,507.20 Cr | 13,126.87 Cr | 4,327.81 Cr |
| 2024-06-30 | -1,099.27 Cr | 2,198.54 Cr | 1,099.27 Cr | 0.00 Cr | 0.00 Cr | 1,099.27 Cr | 0.00 Cr | 0.00 Cr | -8,408.14 Cr |
| 2024-03-31 | 1,099.27 Cr | 160.77 Cr | 1,099.27 Cr | 496.65 Cr | 79.84 Cr | 1,706.18 Cr | 3,691.08 Cr | 11,999.94 Cr | 3,591.80 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 319.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 238.80 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 281.81 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 236.27 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 251.54 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Care Facilities
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Max Healthcare Institute Limited | MAXHEALTH | ₹1,234.70 | ₹1,200,371,493,910.00 | ₹1,487,935.00 |
| Apollo Hospitals Enterprise Limited | APOLLOHOSP | ₹7,922.50 | ₹1,139,136,662,500.00 | ₹843,635.00 |
| Fortis Healthcare Limited | FORTIS | ₹934.40 | ₹705,432,755,200.00 | ₹1,777,868.00 |
| Global Health Limited | MEDANTA | ₹1,384.70 | ₹372,041,749,880.00 | ₹243,552.00 |
| Narayana Hrudayalaya Limited | NH | ₹1,813.70 | ₹370,649,545,700.00 | ₹137,642.00 |
| Aster DM Healthcare Limited | ASTERDM | ₹602.50 | ₹312,167,902,500.00 | ₹919,644.00 |
| Krishna Institute of Medical Sciences Limited | KIMS | ₹736.80 | ₹294,822,415,200.00 | ₹188,342.00 |
| Rainbow Children's Medicare Limited | RAINBOW | ₹1,577.40 | ₹160,187,610,568.00 | ₹38,800.00 |
| HealthCare Global Enterprises Limited | HCG | ₹677.70 | ₹94,481,545,500.00 | ₹76,902.00 |
| Yatharth Hospital & Trauma Care Services Limited | YATHARTH | ₹716.15 | ₹69,004,171,333.00 | ₹283,413.00 |
| Indraprastha Medical Corporation Limited | INDRAMEDCO | ₹459.50 | ₹42,123,743,500.00 | ₹140,362.00 |
| Kovai Medical Center and Hospital Limited | KOVAI | ₹2,581.00 | ₹35,290,787,300.00 | ₹5,780.00 |
| Artemis Medicare Services Limited | ARTEMISMED | ₹238.02 | ₹33,060,978,000.00 | ₹68,033.00 |
Key Executives
No executive data available.
FAQs about Max Healthcare Institute Limited
The CEO is Abhay Soi.
The current price is ₹213.65.
The range is ₹52.3-218.0.
The market capitalization is ₹922.34 crores.
The dividend yield is 0.12%.
The P/E ratio is 104.53.
The company operates in the Healthcare sector.
Overview of Max Healthcare Institute Limited (ISIN: INE027H01010) is a leading Medical - Care Facilities in India. With a market capitalization of ₹922.34 crores and an average daily volume of 0 shares, it operates in the Medical - Care Facilities. The company last declared a dividend of ₹0.